| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |